A decade ago a large part of Big Pharma gave up on one of humanity’s cruellest diseases. But then a new treatment showed promise
How a Swedish start-up reignited the search for an Alzheimer’s drug
Recent Posts
- SK Hynix profits soar sixfold on AI boom
- Zelenskyy reports positive Oval Office meeting as Trump shifts towards Ukraine
- Fifa faces fierce backlash over plans for $20bn commercial stake sale
- US says it intercepted ‘surprise’ Iranian missile attack
- Nvidia revealed as tenant for $50bn data centre that will use its chips
